And while there have been a string of
successful initial public
offerings, including Healthscope's debut last week, this is not enough to
counter the force of more competitively priced funds available in the debt market than the equity market for a company seeking to grow by acquisition.
When you look at it from this perspective, accepting that
counter offer was less of a mistake and more of a learning curve, one which will help guarantee that your next step is a
successful one.